Skip to main content

News

By Dave Muoio | 03:30 pm | April 17, 2020
The COVID-19 Telehealth Program and the Connected Care Pilot Program together are set to invest $300 million so that healthcare providers can reach the patients in greatest need of virtual-care services. 
By Tammy Lovell | 02:12 pm | April 17, 2020
The technology by Deputy offers a “touchless clock-in” for staff which enables them to register for work without touching a screen.  
By Tammy Lovell | 01:42 pm | April 17, 2020
The guidance on how to identify and manage symptoms will be provided to all UK GP surgeries. 
By Laura Lovett | 05:14 pm | April 16, 2020
The new tool will be combined with Biofourmis' Biovitals platform and be able to give insights to cancer patients at home. 
By Dave Muoio | 05:10 pm | April 16, 2020
Also: Mercom's Q1 2020 digital health funding report; Fitbit, Scripps, Stanford collaborate on COVID-19 detection research.
03:51 pm | April 16, 2020
Just as it's doing with nearly every facet of society around the world, the COVID-19 crisis will radically transform approaches with patient engagement and pop health. From telemedicine and remote patient monitoring to AI and advanced analytics, healthcare was already in the midst of big changes in how it manages the health of patient populations. Now, in a new era where the pandemic is upending old assumptions, the stakes are even higher. This month, we look at how approaches to treating COVID-19 and other illnesses are shifting in this new era.  
By Dave Muoio | 03:38 pm | April 16, 2020
A new guidance from the U.S. regulator relaxes a handful of requirements for these digital health devices, and clarifies the agency's long-term enforcement policy for low-risk wellness products. 
By Laura Lovett | 01:02 pm | April 16, 2020
The health system is implementing new technologies to help it pinpoint frequent readmissions and identify underlying social determinants of health. 
COVID-19
By Piers Ford | 09:19 am | April 16, 2020
An integrated virtual clinic app has been designed to take the heat out of the struggle to maintain appointment levels when they are under intense stress from the COVID-19 response, as the situation steps up the pace of digital transformation.
By Dean Koh | 04:30 am | April 16, 2020
JN Medsys has obtained approval for their PCR Kit from the FDA of the Philippines, and is in the process of obtaining approval from the US FDA.